🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (July 23, 2011) – Revue de presse (23 juillet 2011)



Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients
Giving the ovaries a rest when young women with breast cancer are
undergoing chemotherapy may help prevent early menopause and preserve
fertility. By Amanda Gardner. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/19/drug-may-prevent-chemo-linked-menopause-in-breast-cancer-patients

Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel
A federal advisory committee voted 9 to 6 on Tuesday that a first-of-
its-kind diabetes drug should not be approved for use because of
safety concerns, including a possible increased risk of breast and
bladder cancers.
By Andrew Pollack. In The New York Times
http://www.nytimes.com/2011/07/20/business/diabetes-drug-dapagliflozin-rejected-by-fda-panel.html

Builders in skin cancer warning
Researchers at Manchester University found some construction workers
are nine times more likely to get the disease than people doing other
jobs.
By Jim Taylor. In BBC News
http://www.bbc.co.uk/newsbeat/14222009

Stem Cells Help Irradiated Mice Grow New Brain Cells
The study could offer hope for brain cancer patients, who often suffer
dire cognitive problems as a result of radiation treatment.
By Karen Weintraub. MIT Technology Review
http://www.technologyreview.com/biomedicine/38090/?p1=A2

Link found between male hormone, liver cancer
Androgen, or male hormone, may be responsible for the higher morbidity
of liver cancer among men than women, researchers at the Chinese
University of Hong Kong (CUHK) have found. By Andrea Deng. In China
Daily
http://www.chinadaily.com.cn/hkedition/2011-07/20/content_12938670.htm

UK cost agency rejects Eisai breast cancer drug (Halaven (eribulin))‎
The National Institute for Health and Clinical Excellence (NICE) said
on Wednesday it was not able to recommend the medicine for the
treatment of locally advanced or metastatic breast cancer, following
chemotherapy.
By Ben Hirschler. Reuters
http://www.reuters.com/article/2011/07/19/eisai-britain-idUSL6E7IJ1W620110719

Herceptin + Chemotherapy Results in Better Survival in HER2-Positive
Breast Cancer Patients
Results from a prospective study of 1023 newly-diagnosed HER2-positive
metastatic breast cancer patients show that treatment with
trastuzumab(Drug information on trastuzumab) (Herceptin) and
chemotherapy independently resulted in statistically significant
improvement in median overall survival from the time central nervous
system (CNS) metastases were diagnosed.
By Anna Azvolinsky. In Cancer Network
http://www.cancernetwork.com/breast-cancer/content/article/10165/1909629

Specialists More Likely to Spot Deadly Skin Cancer
Melanoma, the most dangerous type of skin cancer, can be found by
patients themselves, but new research reveals that self-detection is
not as effective as screenings performed by doctors.  In U.S. News &
World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/18/specialists-more-likely-to-spot-deadly-skin-cancer

New lung cancer gene found
Cancer biologists identify a driving force behind the spread of an
aggressive type of lung cancer.
By Anne Trafton. MIT News
http://web.mit.edu/newsoffice/2011/lung-cancer-gene-0719.html

Denosumab approved in Europe
Amgen today announced that the European Commission (EC) has granted
marketing authorization for denosumab for the prevention of skeletal-
related events (SREs) (pathological fracture, radiation to bone,
spinal cord compression or surgery to bone) in adults with bone
metastases from solid tumors.
ecancermedicalscience
http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=1888

Tall people 'more likely to develop cancer'
Being tall has been linked to a greater risk of 10 common cancers by
University of Oxford researchers. For every four inches (10cm) above
five feet a person was, the researchers said they had a 16% increased
cancer risk.
BBC News
http://www.bbc.co.uk/news/health-14230731

Le cancer pourrait se répandre dans les pays pauvres (médecin)
Faute de mesures efficaces comme la mise en place de programmes
nationaux de lutte contre le cancer, cette maladie se répandra sous
ses différentes formes dans les pays en développement, ceux d’Afrique
surtout, a prévenu le cancérologue sénégalais Abdoul Aziz Kassé,
samedi à Dakar.
Agence de Presse sénégalaise
http://www.aps.sn/aps.php?page=articles&id_article=82496

Plus de risques de cancer chez les femmes de grande taille
Les femmes de grande taille auraient plus de risques de développer un
cancer. Voilà les conclusions d'une étude de l'université d'Oxford
publiée dans la revue scientifique The Lancet Oncology jeudi.
Dans Le Monde
http://bigbrowser.blog.lemonde.fr/2011/07/22/genetique-plus-de-risques-de-cancer-chez-les-femmes-de-grande-taille/





Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – Oncowal & Wallogene (07/2011)